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Summary.-Experience with the macrophage electrophoretic mobility (MEM)
test of Field and Caspary in subjects with malignant and non-malignant disease is
reported. There was some discrimination between groups of patients with benign
and malignant lesions but there was no clear separation between the groups. A
trial of the Cardiff modification of the test failed to discriminate between groups of
patients with benign and malignant chest disease. In the view of the authors the
MEM test in its present form is not sufficiently reproducible to warrant more general
clinical application as an in vitro test for cancer.
FIELD and Caspary (1970) developed
a new in vitro test of delayed hyper-
sensitivity based on changes in the
electrophoretic mobility of guinea-pig
peritoneal macrophage cells in the pre-
sence of antigen and specifically sensitized
lymphocytes. These authors have de-
scribed applications of the test to a
number of human disease states (Field,
1972) although the majority of the claims
have not yet been confirmed indepen-
dently. Of particular interest and clinical
importance is the test for cancer which
Field, Caspary and Smith (1973) reported
to give positive results in 463 of 464
patients with cancer of various types and
extent. The original cancer test of Field
and Caspary (1970) was based on sensitiza-
tion to the encephalitogenic factor (EF),
derived from brain material, and sensiti-
zation to the substance appears a rational
explanation for the non-metastatic neuro-
pathies seen in cancer patients. Later it
was claimed that there is a basic protein
which is confined to neoplastic tissue
(Dickinson, Caspary and Field, 1973) to
which patients with cancer become sensi-
tized (Caspary and Field, 1971). The
implications for diagnosis and therapy are
far-reaching.
The cancer test has been verified
independently by Pritchard et al. (1973);
these authors also introduced some tech-
nical modifications which increased the
discriminatory sensitivity of the test.
Our preliminary results (Goldstone, Kerr
and Irvine, 1973) appeared to substantiate
the claims regarding the cancer test and
we report here further experience.
In the original (Newcastle) method
lymphocytes, antigen and peritoneal
macrophages are incubated together at
23°C for 90 min and the electrophoretic
mobilities of the macrophages are mea-
sured in a Zeiss cytopherometer. Lym-
phocytes sensitized to the antigen in use
are thought to release a soluble mediator
which alters the surface charge and
hence the electrophoretic mobility of the
macrophages. Slowing of macrophage
migration in the presence of antigen is
taken to indicate lymphocyte sensitiza-
tion. The test is carried out in two stages
in the (Cardiff) method developed by
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Pritchard et al. (1973): (i) antigen is
incubated with lymphocytes for 90 min
at 23°C and (ii) the supernatant medium,
after removal of the lymphocytes by
centrifugation, is added to a suspension of
macrophages and then incubated for a
further 90 min at 37°C. The electro-
phoretic mobility of the macrophages is
then read as in the Newcastle method.
We have used both the Newcastle test
and the Cardiff modification in two small
trials in groups ofpatients with cancer and
other disorders.
PATIENTS AND METHODS
Blood was obtained from healthy labora-
tory staff, patients in a general medical ward,
patients attending a breast clinic and patients
in a chest disease unit. In the last two
groups of subjects the nature of the patients'
breast leasions or chest disease was ascer-
tained after the test had been made. Speci-
mens were coded randomly by independent
workers so that the cytopherometer operator
was not aware of the specific source of the
specimen being read. Fifteen ml of venous
blood were defibrinated by shaking with glass
beads for the Newcastle test. Excessive
shaking resulted in haemolysis and this was
found during the preliminary work to be
associated with slowing of macrophage
migration. For this reason, as well as con-
venience anticoagulation with preservative-
free heparin (20 i.u./ml) was used for the
second trial (Cardiff test). Preliminary work
failed to demonstrate any difference between
the results of tests using lymphocytes pre-
pared from defibrinated and heparinized
blood. Lymphocytes isolated from the de-
fibrinated or heparinized blood by Ficoll-
Triosil density gradient centrifugation were
washed 3 times in medium 199 and resus-
pended at a final concentration of 1 x 106/ml.
Guinea-pig peritoneal macrophage cells were
produced by the intraperitoneal injection of
20 ml of warm sterile liquid paraffin into
albino Hartley guinea-pigs weighing in
excess of 250 g. After 6-10 days the guinea-
pigs were killed by exsanguination and the
exudate harvested by peritoneal lavage with
80 ml balanced salt solution (BSS). Sterility
was maintained as far as possible. Field et
al. (1973) have emphasized the importance of
a healthy guinea-pig population, healthy
36
animals being necessary to produce healthy
exudates. Animals in poor health, especially
males, produced poor haemorrhagic exudates.
Non-specific slowing of macrophage migra-
tion was found with such exudates during the
preliminary experiments and only " clean"
exudates were used subsequently. The exu-
date cells were washed 3 times in BSS and
finally resuspended in medium 199 at a
concentration of 1 x 107/ml. The exudate
was irradiated with 200 rad from an x-ray
source to suppress any xenogeneic mixed
lymphocyte response (Caspary and Field,
1971). Cancer basic protein antigen (CaBP)
(Dickinson and Caspary, 1973) prepared by
Dr J. P. Dickinson was kindly supplied and
used as directed by Mr E. A. Caspary.
Electrophoretic mobility times were meas-
ured at 23°C with a Zeiss cytopherometer at a
potential of 190 mV and 9-5 mA across the
electrodes. Macrophage cells in focus in the
stationary plane were identified by their
paraffin droplet content and only cells
approximately filling one square of the
microscope eyepiece graticule were timed
(Shenton, Hughes and Field, 1973). The
time taken for a selected cell to migrate
across one graticule square was recorded in
both directions of current flow and generally
only pairs of timings with less than 10%
variation were accepted. Ten pairs of read-
ings of similar order were recorded for each
specimen. The problem ofmigration bias or
" drift " was partially controlled by screw
clamps on the flexible tubing connected to the
electrode system.
In the first trial using the Newcastle test
0-5 X 106 lymphocytes, 1 x 107 macro-
plhages and 100 ,4g CaBP in a total of 3.1 ml
of medium 199 were incubated for 90 min at
23°C before reading. In the second trial
using the Cardiff modified test 1 X 106
lymphocytes were incubated with 100 ,ug
CaBP in a total of 2-1 ml medium 199; after
90 min at 23°C the supernatant was added to
1 x 107 macrophages in 1 ml of medium and
after a further 90 min at 37°C the electro-
phoretic times in the control and test speci-
mens were read.
RESULTS
A satisfactory degree of consistency in
macrophage timings was obtained before
starting the trials. For example, the
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mean timings ±S.D. of 10 selected cells
in the control specimens on successive
occasions during the breast trial were (in
seconds) 2-82 ± 0-115, 2-87 ± 0-158, 2*82
0.111, 2-84 ± 0-124, 2'74 ± 0-142, 2*86
± 0*083, 2-83 ± 0-122, 2*91 ± 0-113.
The results are shown in the accom-
panying figures and are expressed as
mean percentage change in migration time
(MEM) in test specimens compared with
specimens to which antigen had not been
added. A positive result denotes slowing
ofmacrophage migration and by inference
lymphocyte sensitization to the antigen.
The groups studied were as follows:
First trial (Newcastle method). Fig 1, 2.
(i) One normal subject (R.L.) tested on
5 separate occasions. Range + 7% to
-155%; (ii) 10 normal subjects each tested
on one occasion. Range +7% to -2%;
(iii) 9 patients with various types of
non-malignant disease. Range + 8%
to -6%; (iv) 17 patients with mis-
cellaneous types of cancer being treated in
general medical wards. Range +15% to
-12%; (va) 8 patients with benign breast
lesions. Range +3-8 to -4%; (vb) 9
patients with malignant breast lesions.
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FIG. 1.-Macrophage electrophoretic mobility slowing with cancer basic protein in normal subjects,
patients with non-malignant disease, and miscellaneous varieties of cancer. Newcastle test.
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FIG. 2.-Macrophage electrophoretic mobility
slowing with cancer basic protein in
patients with benign and malignant breast
lumps. Newcastle test.
Range +15% to -14%.
The results for patients in group (v)
were classified some time after the tests
were made, when the histological nature
of the p2tients' lesions became known. In
a few instances incubation with CaBP
produced accelerated macrophage migra-
tion times. The explanation of these
anomalous results is unknown.
Second trial (Cardiff method) Fig. 3.
(i) Seven patients with well advanced, but
not terminal, lung cancer. Range +12%
FIG. 3.-Macrophage electrophoreticmobility slowing with cancer basic protein in
patients with benign and malignant chest
disease. Cardiff test.
to -3.6%; (ii) 7 patients with non-malig-
nant disease attending the chest clinic.
Range +3-4 to -0.2%.
DISCUSSION
The concept of tumour associated
antigens has stimulated many attempts to
develop immunological methods of diag-
nosing and treating cancer. In recent
years cancer immunodiagnosis has ad-
vanced significantly with the discovery of
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oncofoetal antigens (Alexander, 1972).
Radioimmunoassay methods, with high
degrees of accuracy reproducibility, have
quite rapidly given the detection of these
antigens a place in the clinical sphere.
The Field and Caspary cell mediated test
for cancer has entered a new area of
immunodiagnosis and has been claimed to
produce remarkable consistency of diag-
nostic accuracy, albeit with occasional
false positive results (Field et al., 1973).
Clearly, if reproducible, this test would
represent another important clinical ad-
vance. The report by Field and his
colleagues concerning cancer and other
human disease states appears to demon-
strate that the macrophage electrophoretic
mobility test is the most sensitive in vitro
test of cell mediated sensitization so far
developed. It is therefore surprising that
the technique has not received widespread
attention in the years since the initial
description. The independent confirma-
tion of the cancer test by Pritchard et al.
(1973) and our initial results (Goldstone
et al., 1973) support the claims ofField and
Caspary, but our recent results are less
encouraging. Two principal aspects are
discussed here, the technology of the test
and its value as a means of cancer im-
munodiagnosis.
Operation of the Zeiss cytopherometer
is difficult to standardize and much
depends on the subject-ve skill and ex-
perience of the operator. Recurrent
problems with " drift ", microleaks and
bubbles can be solved only by working
with extreme patience and caution. The
electrophoresis system of the Zeiss cyto-
pherometer requires a relatively large
volume (3 ml), and consequently large
numbers of cells, to fill the chamber and
its associated tubing. We have found a
closed circuit television monitor to be
helpful in reading test specimens but this
does not overcome the problems of large
chamber size and unsatisfactory electrode
assemblies. A capillary type of electro-
phoresis cell may be advantageous (Preece
and Light, 1974).
Oil induced guinea-pig peritoneal
exudates usually contain 15-20% lympho-
cytes and the remaining macrophage cells
are highly variable in morphological
appearance. It is unlikely that the
macrophages are functionally homoge-
neous and some cells are probably more
susceptible to the mediator of macrophage
electrophoretic mobility alteration than
are others. Shenton et al. (1973) have
described variable electrophoretic mobility
in different morphological types of macro-
phage in the cytopherometer and have
shown that spurious results are obtained
if the wrong type of cell is selected for
timing. Our present results follow the
suggestions of Shenton et al. (1973)
regarding cell selection. Functional heter-
ogeneity of macrophage subpopulations
has been shown by Walker (1974), having
separated the cells by discontinuous
density gradient centrifugation. Unfor-
tunately the yield of cells at each interface
is relatively small compared with the
capacity of the cytopherometer chamber
and the use of sub-populations of macro-
phages in the electrophoretic mobility test
does not yet appear feasible.
In the Newcastle test lymphocytes are
separated by methyl celluloseandcarbonyl
iron sedimentation, whereas we have used
the more rapid method of Ficoll-Triosil
density gradient centrifugation adopted
by Pritchard et al. (1973) in the Cardiff
modification. This difference from the
Newcastle protocol might explain why
our results are less clear-cut than theirs but
if this is the reason more satisfactory dis-
crimination would have been expected in
the second trial using the Cardiff test and
the reverse was found.
The series of results presented here is
small relative to those series reported by
the Newcastle and Cardiff groups. How-
ever, these results were obtained after
several months of preliminary work and
at a time when problems had been
resolve(d concerning operation of the
cytopherometer and health of the guinea-
pig population.
In the first trial (Newcastle test) there
was some discrimination between groups
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with malignant conditions and benign
conditions but the significance of the
difference is uncertain. The evidence for
cell mediated immunity to the " cancer
basic protein " is no more than circum-
stantial.
If the results of Field and Caspary
(1970) and of Pritchard et al. (1973) are
accepted, they indicate an exceptional
type of cell mediated response which
takes place at 23°C and may be complete
within 45 min (Field et al., 1973). Caspary
(1971) has suggested that the mediator
resembles migration inhibition factor
(MIF) but the rapidity of this reaction
contrasts with the many hours incubation
at 37°C necessary to produce sufficient
MIF in lymphocyte cultures to be effective
in the conventional macrophage migration
inhibition test. This difference may be
merely a matter of the quantity of media-
tor substance concerned but the nature
of the mediator substance, whether it be
MIF or something else, is clearly of
central importance in understanding the
electrophoretic mobility test. Isolation of
the mediator couldleadtothedevelopment
ofa more satisfactory method ofassay and
hence more general application of the
technique (Nature, Lond., 1973).
The disparity between our recent
findings with the macrophage electro-
phoretic mobility test and previously
reported series may well be the result of
some technical failure despite attempts to
follow the Newcastle and Cardiff protocols
as closely as possible. In our view the
macrophage electrophoretic mobility test
for cancer in its present form is not readily
reproducible. Caution is necessary in its
interpretation and further refinement is
required before widespread clinical appli-
cation can be suggested.
The new fluorescence polarization tech-
nique of Cercek, Cercek and Franklin
(1974) may have more widespread clinical
application as a test of sensitization to
cancer antigens.
We wish to thank Mr E. A. Caspary for
technical advice and Dr J. P. Dickinson
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